MedPath

octurnal free fatty acids. Measurements in obese and lean subjects and the effect of beta-blockage on pulsatile release.

Conditions
10018424
insulin resistance
Registration Number
NL-OMON32829
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Kaukasische man met een BMI > 30 kg/m2 of een BMI 20<25 kg.m2.

Exclusion Criteria

* any chronic medical condition or use of any medication
* asthma and bronchospastic COPD
* tobacco use
* alcohol abuse (>3/day)
* frequent intensive exercise (>2 week)
* familial lipid disorders, renal insufficiency (creatinine > 150 umol/L) , elevated liver enzymes (> 2 times), hypertension
* Hypotension (BP < 100/60 mmHg), bradycardia (HR < 60min)
* unwilling or unable to provide informed consent
* first degree family members with diabetes
* abnormal day/night rhythm (shiftworkers etc)
* Blood donation in the past three months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1. Percent and/or absolute changes in nocturnal FFA levels with or without *-<br /><br>blockage.<br /><br>2. Difference in nocturnal FFA levels between lean and obese subjects.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Phenotypical differences (adipose tissue distribution, plasma parameters)</p><br>
© Copyright 2025. All Rights Reserved by MedPath